399 related articles for article (PubMed ID: 10604006)
1. [Scleroderma in children: a retrospective study of 70 cases].
Bodemer C; Belon M; Hamel-Teillac D; Amoric JC; Fraitag S; Prieur AM; De Prost Y
Ann Dermatol Venereol; 1999 Oct; 126(10):691-4. PubMed ID: 10604006
[TBL] [Abstract][Full Text] [Related]
2. [Localized scleroderma: a retrospective study about 92 cases].
El Fékih N; Réjaibi I; Kamoun H; Zéglaoui F; Fazaa B; Kharfi M; Kamoun MR
Tunis Med; 2009 Sep; 87(9):573-8. PubMed ID: 20180376
[TBL] [Abstract][Full Text] [Related]
3. "Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases.
Prinz JC; Kutasi Z; Weisenseel P; Pótó L; Battyáni Z; Ruzicka T
J Am Acad Dermatol; 2009 Feb; 60(2):248-55. PubMed ID: 19022534
[TBL] [Abstract][Full Text] [Related]
4. Localized scleroderma: a series of 52 patients.
Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
[TBL] [Abstract][Full Text] [Related]
5. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases.
Marzano AV; Menni S; Parodi A; Borghi A; Fuligni A; Fabbri P; Caputo R
Eur J Dermatol; 2003; 13(2):171-6. PubMed ID: 12695134
[TBL] [Abstract][Full Text] [Related]
6. [Linear scleroderma in children (apropos of 27 cases)].
Larrègue M; Ziegler JE; Lauret P; Bonafe J; Lorette G; Titi A; Ramdenee P; Bressieux JM
Ann Dermatol Venereol; 1986; 113(3):207-24. PubMed ID: 3752860
[TBL] [Abstract][Full Text] [Related]
7. [Scleroderma in a hospital setting in Togo].
Pitche P; Amanga Y; Koumouvi K; Oniankitan O; Mijiyawa M; Tchangaï-Walla K
Med Trop (Mars); 1998; 58(1):65-8. PubMed ID: 9718559
[TBL] [Abstract][Full Text] [Related]
8. [Lichen planus in children: 12 cases].
Rybojad M; Moraillon I; Laglenne S; Vignon-Pennamen MD; Bonvalet D; Prigent F; Saada V; Merle F; Crouzet F; Cambiaghi S; Morel P
Ann Dermatol Venereol; 1998 Oct; 125(10):679-81. PubMed ID: 9835955
[TBL] [Abstract][Full Text] [Related]
9. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
10. [Prognosis and treatment of scleroderma].
Crickx B; Belaich S
Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058
[TBL] [Abstract][Full Text] [Related]
11. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease.
Hedrich CM; Fiebig B; Hahn G; Suttorp M; Gahr M
Clin Pediatr (Phila); 2011 Jul; 50(7):604-14. PubMed ID: 21525084
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic changes in linear scleroderma in children. Apropos of 11 cases].
Fontan I; Taïeb A; Guillet G; Rommel A; Fontan D; Maleville J
Ann Dermatol Venereol; 1988; 115(2):135-41. PubMed ID: 3293512
[TBL] [Abstract][Full Text] [Related]
13. Localized scleroderma in childhood is not just a skin disease.
Zulian F; Vallongo C; Woo P; Russo R; Ruperto N; Harper J; Espada G; Corona F; Mukamel M; Vesely R; Musiej-Nowakowska E; Chaitow J; Ros J; Apaz MT; Gerloni V; Mazur-Zielinska H; Nielsen S; Ullman S; Horneff G; Wouters C; Martini G; Cimaz R; Laxer R; Athreya BH;
Arthritis Rheum; 2005 Sep; 52(9):2873-81. PubMed ID: 16142730
[TBL] [Abstract][Full Text] [Related]
14. [Scleroderma].
Scharffetter K; Kind P; Wollny-Protzel D; Schuppe HC; Lakomek HJ; Goerz G
Z Hautkr; 1990 Mar; 65(3):237-42, 245-6. PubMed ID: 2187309
[TBL] [Abstract][Full Text] [Related]
15. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
[TBL] [Abstract][Full Text] [Related]
16. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea.
Falanga V; Medsger TA; Reichlin M
Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090
[TBL] [Abstract][Full Text] [Related]
17. Relationship between occupational risk factors and severity markers of systemic sclerosis.
Magnant J; de Monte M; Guilmot JL; Lasfargues G; Diot P; Asquier E; Degenne D; Boissinot E; Diot E
J Rheumatol; 2005 Sep; 32(9):1713-8. PubMed ID: 16142866
[TBL] [Abstract][Full Text] [Related]
18. [Systemic scleroderma in children].
Plantin P; Gavanou J; Le Fur JM; Guillet G
Arch Fr Pediatr; 1988 Dec; 45(10):805-8. PubMed ID: 3266459
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous manifestations of selected rheumatologic diseases.
Ostezan LB; Callen JP
Am Fam Physician; 1996 Apr; 53(5):1625-36. PubMed ID: 8623690
[TBL] [Abstract][Full Text] [Related]
20. [Incapacitating pansclerotic morphea in childhood].
Ferrandiz C; Henkes J; González J; Peyri J
Med Cutan Ibero Lat Am; 1981; 9(5):377-82. PubMed ID: 7038353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
